Explains the signs and symptoms of retraumatization. Gives guidance on how to manage the symptoms. Provides resources for building resilience and an adequate support system for dealing with triggering events. Inventory#: SMA17-5047
As I wrap up matters here at NIH and think over my tenure as Director of this Center, I have a few very brief final reflections. The topic of this post is scientific curiosity.
A federal district judge in Atlanta has issued an order finding several defendants, including repeat offender Jared Wheat, in contempt for violating previous court orders related to the sale of weight-loss dietary supplements. The order imposes a more than $40 million judgment against the defendants, part or all of which the Federal Trade Commission may use to provide refunds to deceived consumers who bought the products.
Newark, CA, Gadget Island, Inc. is voluntarily recalling Rhino 7 Platinum 5000 capsules, All LOTS, Papa Zen 3300 capsules, LOT# NSS050888, Fifty Shades 6000 capsules, all Lots, Grande X 5800 capsules, all Lots, to the consumer level. FDA analysis has found the products to be tainted with Sildenafil and Tadalafil, which are the active ingredients in two FDA-approved prescription drugs used for the treatment of erectile dysfunction (ED), as well as Desmethyl Carbodenafil which is structurally similar to sildenafil.
Kiriko, LLC. is voluntarily recalling all lots of A1 Slim 30 capsules bottle to the consumer level. FDA laboratory analysis has found the A1 Slim product to be tainted with sibutramine, phenolphthalein and N-Desmethyl sibutramine.
These undeclared ingredients make this product an unapproved new drug for which safety and efficacy have not been established; therefore, subject to recall.
I am proud to announce NIH’s newest interagency research initiative on pain management in military service members and veterans.
NCCIH, lead for this multi-agency initiative called the NIH-DoD-VA Pain Management Collaboratory, is contributing more than half the funding for these 12 projects to develop, implement, and test nondrug approaches for managing pain and its related conditions in the military and veteran population―including opioid misuse, abuse, and disorder. The total funding for this project will be $81 million over 6 years.
If you are planning to submit a grant application that includes human subjects to NCCIH this fall, we want to help you select the best funding opportunity announcement (FOA) to use.
This report presents 2016 national estimates of use of alcohol, tobacco products, illicit drugs (such as, marijuana, cocaine, heroin, hallucinogens, and inhalants, as well as the misuse of opioids, prescription pain relievers, tranquilizers, stimulants, and sedatives), substance use disorders, and substance use treatment among people 12 years of age and older. It Includes national estimates of any mental illness, serious mental illness, major depressive episode, use of mental health services and suicidal ideation among adults ages 18 or older and national estimates of major depressive episode, use of mental health services among adolescents aged 12 to 17. Trend information on these topics are also presented. Inventory#: SMA17-5044
A component of SAMHSA’s Wellness initiative, this poster emphasizes “Focus on the Physical,” and shows a variety of images of people living a healthy lifestyle such as exercising, sleeping, getting routine checkups, etc. Inventory#: SMA16-4956
This resource guide for parents offers advice on keeping children substance free. Review statistics about adolescent substance use, and learn tips on good communication. The guide also features substance facts and case studies for additional insight. Inventory#: SMA17-3772
This report highlights the structure, responsibilities, policies, services, and financing of single-state agencies and state mental health agencies. The report includes discussion of efforts to integrate physical and behavioral health and efforts by state agencies to address opioid abuse and misuse. Inventory#: SMA17-5029
Provides Health Care Practitioners and Disaster Responders with guidelines for communicating with survivors experiencing grief. Background information about the grieving process and what happens when the grief process is interrupted and complicated or traumatic grief occurs is included as well as helpful resources for additional assistance. Inventory#: SMA17-5036
This tip sheet contains information about grief, the grieving process, and what happens when the process is interrupted and complicated or traumatic grief occurs. It also offers tips and resources for coping with both types of grief. Inventory#: SMA17-5035
This report presents national data about the prevalence of behavioral health conditions. This data includes the rate of serious mental illness, suicidal thoughts, substance use, and underage drinking. The report also highlights the percentages of those who seek treatment for these conditions. Access state barometer reports. Inventory#: SMA17-BAROUS-16
Provides caregivers with a general overview of anxiety disorders in youth and young adults. Gives guidance on how to provide support. Highlights recommended treatment approaches. Includes a list of helpful resources. Inventory#: SMA16-5009
Gives young adults facts on living with obsessive-compulsive disorder. Discusses causes and treatment approaches. Provides a list of helpful resources.
*508 compliant version coming soon Inventory#: SMA16-5002
Provides caregivers with a general overview of obsessive-compulsive disorder in youth and young adults. Gives guidance on how to provide support. Highlights recommended treatment approaches. Includes a list of helpful resources. Inventory#: SMA16-5001
Gives young adults facts on living with psychosis. Discusses causes and treatment approaches. Provides a list of helpful resources.
*508 compliant version coming soon Inventory#: SMA16-5006
Gives young adults facts on living with attention-deficit/hyperactivity disorder. Discusses causes and treatment approaches. Provides a list of helpful resources. Inventory#: SMA16-5012